Education
About Us
Working with TipRanks
Follow Us
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS
Corvus Pharmaceuticals (CRVS) Ownership Overview
34.59% Insiders
4.68% Mutual Funds
43.70% Other Institutional Investors
4.70% ETFs
12.32% Public Companies and
Individual Investors
The ownership structure of Corvus Pharmaceuticals (CRVS) stock is a mix of institutional, retail, and individual investors. Approximately 53.08% of the company’s stock is owned by Institutional Investors, 34.59% is owned by Insiders, and 12.32% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 07, 2024 | Richard A. Miller President & Ceo,director | xxxxxxxxxxxxx | $999307 |
| May 07, 2024 | William Benton Jones Svp, Pharmaceutical Development | xxxxxxxxxxxxx | $34600 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $97931 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $414625 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $624050 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $5350000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,943,654 | Insider | 10.81% | 31,385,316 | |
| 6,943,654 | Insider | 10.81% | 31,385,316 | |
| 3,684,010 | Insider | 7.19% | 16,651,725 | |
| 3,275,616 | Insider | 5.10% | 14,805,784 | |
| 2,374,904 | Institution | 3.70% | 10,734,566 | |
| 2,374,904 | Institution | 3.70% | 10,734,566 | |
| 1,000,000 | Institution | 1.56% | 4,520,000 | |
| 535,913 | Institution | 0.83% | 2,422,327 | |
| 483,733 | Institution | 0.75% | 2,186,473 | |
| 282,444 | Insider | 0.44% | 1,276,647 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,374,904 | Institution | 3.70% | 10,734,566 | |
| 483,733 | Institution | 0.75% | 2,186,473 | |
| 40,000 | Institution | 0.06% | 180,800 | |
| 33,278 | Institution | 0.05% | 150,417 | |
| 29,109 | Institution | 0.05% | 131,573 | |
| 20,514 | Institution | 0.03% | 92,723 | |
| 15,668 | Institution | 0.02% | 70,819 | |
| 10,198 | Institution | 0.02% | 46,095 | |
| 733 | Institution | <0.01% | 3,313 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,621,310 | Institution | 2.52% | 6,550,092 | |
| 793,143 | Institution | 1.23% | 3,204,298 | |
| 303,459 | Institution | 0.47% | 1,371,635 | |
| 95,194 | Institution | 0.15% | 430,277 | |
| 73,776 | Institution | 0.11% | 333,468 | |
| 59,353 | Institution | 0.09% | 268,276 | |
| 31,742 | Institution | 0.05% | 142,839 | |
| 19,711 | Institution | 0.03% | 89,094 | |
| 10,869 | Institution | 0.02% | 48,911 | |
| 10,082 | Institution | 0.02% | 45,571 |
FAQ
Who Owns Corvus Pharmaceuticals Inc (CRVS)?
According to the latest TipRanks data, approximately 43.70% of the company's stock is held by institutional investors, 34.59% is held by insiders, and 12.32% is held by retail investors.
What percentage of Corvus Pharmaceuticals Inc (CRVS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 43.70% of Corvus Pharmaceuticals Inc (CRVS) stock is held by institutional investors.
What percentage of Corvus Pharmaceuticals Inc (CRVS) stock is held by retail investors?
According to the latest TipRanks data, approximately 12.32% of Corvus Pharmaceuticals Inc (CRVS) stock is held by retail investors.
Who owns the most shares of Corvus Pharmaceuticals Inc (CRVS)?
Peter A. Thompson owns the most shares of Corvus Pharmaceuticals Inc (CRVS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.